Biogen Idec to Present at the Deutsche Bank 37th Annual Healthcare Conference
WESTON, Mass.--(BUSINESS WIRE)--May. 2, 2012--
Biogen Idec Inc. (NASDAQ: BIIB) announced today that its presentation at
the Deutsche Bank 37th Annual Healthcare Conference will be
webcast live on Tuesday, May 8, 2012 at 10:00 a.m. ET. To access the
live webcast, please visit Biogen Idec’s Investor Relations section (www.investor.biogenidec.com).
An archived version of the webcast will be available for 14 days
following the presentation.
About Biogen Idec
Through cutting-edge science and medicine, Biogen Idec discovers,
develops and delivers to patients worldwide innovative therapies for the
treatment of neurodegenerative diseases, hemophilia and autoimmune
disorders. Founded in 1978, Biogen Idec is the world’s oldest
independent biotechnology company. Patients worldwide benefit from its
leading multiple sclerosis therapies, and the company generates more
than $5 billion in annual revenues. For product labeling, press releases
and additional information about the company, please visit www.biogenidec.com.
Source: Biogen Idec Inc.
Biogen Idec
Karen Jewell, 781-464-2442
Investor Relations
